Patents for C07D 307 - Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom (47,108) |
---|
04/30/2002 | US6380243 Including human cytomegalovirus, herpes simplex viruses, epstein-barr virus, varicella-zoster virus, human herpesviruses- 6 and -7, and kaposi herpesvirus. |
04/30/2002 | US6380196 Bronchial therapeutics, bronchial dilators |
04/30/2002 | US6380188 For inhibiting human immunodeficiency virus protease |
04/30/2002 | US6379658 Consisting of beta-naphthyl methyl ether, beta-naphthyl ketone, benzyl acetone, hexahydro-4,7-methanoinden-5-yl and 6-yl propionates, gamma-methyl ionone, furan derivative, 3,7-dimethyl-2,6-nonadien-1-nitrile, cyclic ester, ketone |
04/30/2002 | US6379655 For protection of human skin and/or hair against the damaging effects of ultraviolet irradiation |
04/30/2002 | US6379552 Method for resolving optical isomers |
04/30/2002 | CA2187277C Novel derivative of ester of carboxylic acid, the process of manufacturing the same, and insecticide and insect proofing agent containing the same |
04/25/2002 | WO2002032890A1 Process for intramolecular radical cyclization |
04/25/2002 | WO2002032872A1 Nitrogenous aromatic ring compounds |
04/25/2002 | WO2001097810A3 Use of therapeutic benzamide derivatives |
04/25/2002 | WO2001085683A3 Pyrrolyl-, furanyl- and thienyl-substituted p-aminophenols and colorants containing said compounds |
04/25/2002 | WO2001081333A3 Regioselective synthesis of 3,4-di(carbocyclyl or heterocyclyl)thiophenes |
04/25/2002 | WO2001060174A3 Weight loss induced by reduction in neuropeptide y level |
04/25/2002 | US20020049344 New vitamin d derivatives with carbo-or heterocyclic substituents at c-25, a process for their production, intermediate products and their use for producing medicaments |
04/25/2002 | US20020049319 Process for preparing 3-(1-hydroxyphenyl-1-alkoximinomethyl)dioxazines |
04/25/2002 | US20020049288 Metal-ligand complex precursor composition of an amine containing ligand of given formula and group 3,4, or lanthanide metal compound; polymerizing alpha-olefins, higher comonomer content of C4+ olefins |
04/25/2002 | US20020049251 Wedelolactone and its synthesis for treating neurodegenerative diseases |
04/25/2002 | US20020049211 Combination treatment for depression and anxiety |
04/25/2002 | US20020049209 Dopamine D4 ligands for the treatment of novelty-seeking disorders |
04/25/2002 | US20020049201 Sulfonamide inhibitors of aspartyl protease |
04/25/2002 | US20020049185 Malonic acid based matrix metalloproteinase inhibitors |
04/25/2002 | US20020048796 Generating preferential particle; incubate starch and oligosaccharide, oxidize mixture, cyclize mixture, recover preferential compound |
04/25/2002 | DE10050492A1 New butenolide or pentenolide amide derivatives, useful as kinase inhibitors for treating inflammatory and autoimmune diseases, e.g. rheumatoid arthritis, asthma, Alzheimer's disease or osteoarthritis |
04/25/2002 | DE10050490A1 New butenolide or pentenolide amide derivatives, useful as kinase inhibitors for treating inflammatory and autoimmune diseases, e.g. rheumatoid arthritis, asthma, Alzheimer's disease or osteoarthritis |
04/24/2002 | EP1199304A1 Bicyclic compounds and pharmaceutical composition containing tricyclic compound for treating or preventing sleep disorders |
04/24/2002 | CN1083450C Processes for preparing intermediate product used in method of diastereoselective syntheses of nucleosides |
04/24/2002 | CN1083439C 2-amino-4-bicyclomino-1,3,5-triazines as herbicides and plant growth regulators |
04/24/2002 | CN1083416C High productivity process for production of maleic anhydride |
04/23/2002 | US6376540 Furan nitrone compounds |
04/23/2002 | US6376539 Antiischemic agents, central nervous system disorders |
04/23/2002 | US6376532 Neurotransmitter |
04/23/2002 | US6376502 Osteoporosis compounds |
04/23/2002 | US6376491 Benzofuran derivatives for treatment or prevention of mycosis in mammals |
04/23/2002 | US6376468 Protein:prenyl transferase inhibitors |
04/23/2002 | US6376429 Controlling weeds |
04/23/2002 | US6376428 Dihalopropene compounds, insecticidal/acaricidal agents containing same, and intermediates for their production |
04/18/2002 | WO2002030929A1 Novel pleuromutilin derivatives |
04/18/2002 | WO2002030892A1 Butenolide and pentenolide derivatives as kinase inhibitors |
04/18/2002 | WO2002030884A2 Sulfide and disulfide compounds and compositions for cholesterol management and related uses |
04/18/2002 | WO2002030883A1 Process for the preparation of thiophenols |
04/18/2002 | WO2002030882A2 Sulfoxide and bis-sulfoxide compounds and compositions for cholesterol management and related uses |
04/18/2002 | WO2002030881A1 Sulfonylguanidine |
04/18/2002 | WO2002030879A2 Carbamic acid compounds comprising a sulfonamide linkage as hdac inhibitors |
04/18/2002 | WO2002030870A2 Substituted c-cyclohexylmethylamine derivatives |
04/18/2002 | WO2002030863A2 Ether compounds and compositions for cholesterol management and related uses |
04/18/2002 | WO2002030860A2 Ketone compounds and compositions for cholesterol management and related uses |
04/18/2002 | WO2002012166A3 Triamine derivative melanocortin receptor ligands and methods of using same |
04/18/2002 | WO2002003995A3 Treatment of male sexual dysfunction |
04/18/2002 | WO2001087830A3 Substituted thioacetamides |
04/18/2002 | WO2001077359A3 Preparation of thiols and derivatives by bio-conversion |
04/18/2002 | WO2001062709A3 Use of 2-phenylene diamine derivatives for the treatment of infections |
04/18/2002 | WO2001055101A3 A new process for the preparation of latanoprost |
04/18/2002 | US20020045777 Used to treat hypercholesterolemia, hyperlipemia, arteriosclerosis, vascular diseases, mycoses, gallstones, hyperproliferative disorders, and treatment and/or prophylaxis of impaired glucose tolerance and diabetes. |
04/18/2002 | US20020045770 Production method of 5-phthalancarbonitrile compound, intermediate therefor and production method of the intermediate |
04/18/2002 | US20020045764 Tubulin binding compounds (COBRA) |
04/18/2002 | US20020045749 Antibacterial agents |
04/18/2002 | US20020045655 Oxime amides and hydrazone amides having fungicidal activity |
04/18/2002 | US20020045645 Lactone integrin antagonists |
04/18/2002 | US20020045629 Sleep, eating and brain disorders, wakefulness promoters; Parkinson's disease, antiischemic agents, stroke, chronic fatigue syndrome; antidepressants; schizophrenia, nervous system disorders; multiple sclerosis, cognition activators |
04/18/2002 | DE10140028A1 Verfahren zur Herstellung von Citalopram A process for the preparation of citalopram |
04/18/2002 | DE10122447A1 Biphenylcarboxamide Biphenylcarboxamides |
04/18/2002 | DE10048716A1 Use of sulfonylguanidine derivatives, mostly new compounds, for treating e.g. pain and neurodegeneration, have affinity for the gabapentin binding site |
04/18/2002 | CA2765409A1 Hydroxamic acid compounds comprising a sulfonamide linkage as hdac inhibitors |
04/18/2002 | CA2425678A1 Sulfoxide and bis-sulfoxide compounds and compositions for cholesterol management and related uses |
04/18/2002 | CA2425674A1 Sulfide and disulfide compounds and compositions for cholesterol management and related uses |
04/18/2002 | CA2425121A1 Ether compounds and compositions for cholesterol management and related uses |
04/18/2002 | CA2424107A1 Sulfonylguanidines |
04/18/2002 | CA2423935A1 Substituted c-cyclohexylmethylamine derivatives |
04/17/2002 | EP1197504A1 Thermoplastic polymer having polar group, use thereof, and unsaturated compounds having polar group |
04/17/2002 | EP1196405A1 A comonomer, and a polymer stabilized with it during polymerization |
04/17/2002 | EP1196397A1 Metabotropic glutamate receptor antagonists and their use for treating central nervous system diseases |
04/17/2002 | EP0977746B1 Process for the production of tetrahydrofuran and gammabutyrolactone |
04/17/2002 | CN1345316A Process for preparation of alpha-methylenelactones and alpha-substituted hydrocarbylidene lactones |
04/17/2002 | CN1345315A Hydroxymatatairesinol in cancer prevention |
04/17/2002 | CN1345314A Amine derivatives as protease inhibitors |
04/17/2002 | CN1345239A Heterocyclic containing biphenyl alpha P2 inhibitors and method |
04/17/2002 | CN1344713A Natural furan-like perfume and its prepn |
04/17/2002 | CN1082955C Process for preparing 3-(1-hydroxyphenyl-1-alkoximinomethyl) dioxazines |
04/17/2002 | CN1082945C Alkoxiyimino acetamide |
04/16/2002 | US6372943 Polyenepolycarboxylic acids, derivatives thereof with respect to carboxyl groups, or salts of these |
04/16/2002 | US6372922 Process for the production of (−) 3,4-divanillyl tetrahydrofuran |
04/16/2002 | US6372783 Enantiomeric compounds for treatment of cardiac arrhythmias and methods of use |
04/16/2002 | US6372778 Sulfonamide inhibitors of aspartyl protease |
04/16/2002 | US6372762 Heterocyclic compounds for nervous system disorders |
04/16/2002 | US6372693 Substituted 2-(3-alkenyl-benzoyl)-cyclohexane-1,3-diones |
04/16/2002 | CA2266629C Taste-masked microcapsule compositions and methods of manufacture |
04/16/2002 | CA2260413C Terpenoid lactone compounds and their production process |
04/16/2002 | CA2087414C Arylcycloalkyl derivatives their production and their use |
04/11/2002 | WO2002028850A1 Promoters for the proliferation and differentiation of stem cells and/or neuron precursor cells |
04/11/2002 | WO2002028829A2 Peptide deformylase inhibitors |
04/11/2002 | WO2002028823A1 Malonamid and malonamic ester derivatives with antithrombotic activity, their preparation and their use |
04/11/2002 | WO2002028820A1 Nitroso diphenylamine derivatives |
04/11/2002 | WO2002028816A1 Substituted 5-amino-1-pentene-3-ol derivatives |
04/11/2002 | WO2002028815A1 Pharmaceutical compounds |
04/11/2002 | WO2002028810A2 Retinoids for the treatment of emphysema |
04/11/2002 | WO2002028776A1 Rare earth or gallium additive composition, methods for preparing same and use thereof as catalyst |
04/11/2002 | WO2002028353A2 Phosphate transport inhibitors |
04/11/2002 | WO2001072688A3 Method for preparing (2s,3r,4s)-4-hydroxyisoleucine and analogues thereof |
04/11/2002 | US20020042517 Omega-carboxyaryl substituted diphenyl ureas as raf kinase inhibitors |
04/11/2002 | US20020042406 Ring opening metathesis of alkenes |